Johan Sigfrid Rask

Ludesi AB offers software application for analysis service. The firm provides bioinformatics solutions to the life science industry. It develops and provides Ludesi image analysis service for 2-dimensional electrophoresis gels. The company was founded by Ola Forsstrom-Olsson and Johan Malmström in 2001 and is headquartered in Lund, Sweden.

Sana Pharma Medical AS develops topical analgesic products. It develops products against various chronic pain conditions, including osteoarthritis of the knee. Its product 2PX provides clinical benefit in the management of both nociceptive and neuropathic pain. The company was founded in 2002 and is headquartered in Oslo, Norway.

Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden.

Action Pharma A/S is an R&D-focused biotech company located in the Nordic Medicon Valley area in Copenhagen, Denmark. Action Pharma was founded in 2000 and has a pipeline of 4 drug candidates in different stages of development, plus additional compounds in discovery and early preclinical development. Action Pharma pursues the discovery and development of new drugs and treatment concepts to treat cardiovascular diseases, inflammatory diseases and metabolic diseases, such as type-II diabetes and obesity. Its drug candidates are modified endogenous peptides with improved efficacy and small chemical entities targeted the melanocortin receptors. In disease models, its drug candidates have shown strong effects in treating and preventing inflammation and organ damage in conditions such as post-surgical organ dysfunction and acute myocardial infarction. A major focus for Action Pharma is treatment candidates for type-II diabetes, obesity and metabolic syndrome. Moreover, several drug candidates have shown effects in treating inflammatory diseases, such as rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis and dermatitis.

InnovationsKapital Nordic Advisors AB (InnovationsKapital) is a venture capital firm founded in 1994. The firm is headquartered in Gothenburg and Stockholm, Sweden.

Novavax AB is engaged in research and development of vaccines. Its products include Matrix and AbiSCO. The company was founded by Bror Morein in 1999 and is headquartered in Uppsala, Sweden.

Part of Chalmers University of Technology Foundation, Encubator AB is an alternative investment manager. The private company is based in Gothenburg, Sweden. The Swedish company was founded in 2004. The CEO is Jonas Berggren.